The ADRU chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ADRU chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The ADRU stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View ADRU Detailed Price Forecast - CNN Money||View ADRU Detailed Summary - Google Finance|
|View ADRU Detailed Summary - Yahoo! Finance||View ADRU Stock Research & Analysis - Zacks.com|
|View ADRU Trends & Analysis - Trade-Ideas||View ADRU Major Holders - Barrons|
|View ADRU Call Transcripts - NASDAQ||View ADRU Breaking News & Analysis - Seeking Alpha|
|View ADRU Annual Report - CompanySpotlight.com||View ADRU OTC Short Report - OTCShortReport.com|
|View ADRU Fundamentals - TradeKing||View ADRU SEC Filings - Bar Chart|
|View Historical Prices for ADRU - The WSJ||View Performance/Total Return for ADRU - Morningstar|
|View the Analyst Estimates for ADRU - MarketWatch||View the Earnings History for ADRU - CNBC|
|View the ADRU Earnings - StockMarketWatch||View ADRU Buy or Sell Recommendations - MacroAxis|
|View the ADRU Bullish Patterns - American Bulls||View ADRU Short Pain Metrics - ShortPainBot.com|
|View ADRU Stock Mentions - StockTwits||View ADRU Stock Mentions - PennyStockTweets|
|View ADRU Stock Mentions - Twitter||View ADRU Investment Forum News - Investor Hub|
|View ADRU Stock Mentions - Yahoo! Message Board||View ADRU Stock Mentions - Seeking Alpha|
|View Insider Transactions for ADRU - SECform4.com||View Insider Transactions for ADRU - Insider Cow|
|View ADRU Major Holdings Summary - CNBC||View Insider Disclosure for ADRU - OTC Markets|
|View Insider Transactions for ADRU - Yahoo! Finance||View Institutional Holdings for ADRU - NASDAQ|
|View ADRU Stock Insight & Charts - FinViz.com||View ADRU Investment Charts - StockCharts.com|
|View ADRU Stock Overview & Charts - BarChart||View ADRU User Generated Charts - Trading View|
Recommendations for GlaxoSmithKline on October 29
Posted on Monday October 29, 2018
Wall Street analysts are estimating that GlaxoSmithKline will report revenues of ~8.02 billion pounds for the third quarter of 2018. GlaxoSmithKline stock has increased ~8.5% over the last 12 months and ~10.8% year-to-date. Analyst recommendations show a 12-month target price of $44.31 per share compared to its last price of $39.32 on October 26.
What Analysts Recommend for Novartis after Q3 Earnings
Posted on Wednesday October 24, 2018
Wall Street analysts estimate that Novartis will report revenues of $13.4 billion during the fourth quarter of 2018, a 4.0% increase in year-over-year revenues as compared to $12.9 billion during the fourth quarter of 2017. The earnings-per-share is estimated at $1.29 during the fourth quarter of 2018. Analysts estimate the net income margin to increase to 22.1% during the fourth quarter of 2018 as compared to 21.8% during the fourth quarter of 2017.
How Novartis’s Innovative Medicines Business Performed in Q3
Posted on Monday October 22, 2018
Novartis’s (NVS) Innovative Medicines business includes prescription products from two business units: Novartis Pharmaceuticals and Novartis Oncology. The Innovative Medicines business contributed over 67.2% of the total revenues for Novartis and saw 6% growth in year-over-year (or YoY) revenues to ~$8.6 billion during the third quarter of 2018.
A Closer Look at Novartis’s Innovative Medicines Segment
Posted on Wednesday October 10, 2018
Novartis’s (NVS) Innovative Medicines segment includes prescription products from two business units: Novartis Pharmaceuticals and Novartis Oncology.